Smith & Nephew SNATS, Inc. (SNN): Price and Financial Metrics


Smith & Nephew SNATS, Inc. (SNN)

Today's Latest Price: $38.98 USD

1.02 (2.69%)

Updated Nov 27 5:00pm

Add SNN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

SNN Stock Summary

  • Smith & Nephew Plc's market capitalization of $17,252,691,700 is ahead of 88.78% of US-listed equities.
  • With a year-over-year growth in debt of 38.31%, Smith & Nephew Plc's debt growth rate surpasses 78.41% of about US stocks.
  • The volatility of Smith & Nephew Plc's share price is greater than that of merely 5.04% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Smith & Nephew Plc are STE, GIB, BRO, ROL, and COO.
  • SNN's SEC filings can be seen here. And to visit Smith & Nephew Plc's official web site, go to www.smith-nephew.com.

SNN Stock Price Chart Interactive Chart >

Price chart for SNN

SNN Price/Volume Stats

Current price $38.98 52-week high $52.26
Prev. close $37.96 52-week low $26.07
Day low $38.36 Volume 261,232
Day high $39.00 Avg. volume 599,912
50-day MA $38.56 Dividend yield 1.44%
200-day MA $39.70 Market Cap 17.07B

Smith & Nephew SNATS, Inc. (SNN) Company Bio


Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The company was founded in 1856 and is based in London, the United Kingdom.

SNN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$38.98$13.75 -65%

We started the process of determining a valid price forecast for Smith & Nephew Plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Smith & Nephew Plc ranked in the 24th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Smith & Nephew Plc ended up being:

  • As a business, SNN is generating more cash flow than 78.67% of positive cash flow stocks in the Healthcare.
  • The business' balance sheet suggests that 6% of the company's capital is sourced from debt; this is greater than merely 16.4% of the free cash flow producing stocks we're observing.
  • SNN's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 42.65% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-66%
1%-65%
2%-65%
3%-65%
4%-64%
5%-64%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as SNN, try ABC, LGND, RMD, VIVO, and A.


SNN Latest News Stream


Event/Time News Detail
Loading, please wait...

SNN Latest Social Stream


Loading social stream, please wait...

View Full SNN Social Stream

Latest SNN News From Around the Web

Below are the latest news stories about Smith & Nephew Plc that investors may wish to consider to help them evaluate SNN as an investment opportunity.

Integra LifeSciences Bails Out Of A Once-Promising Growth Opportunity

Replacement joints and complementary products for the extremities make up one of the best growth markets within orthopedics, but it's not an easy market in which to sustain success - small, innovative startups are disrupting the market (including hiring away reps), while more established players like Stryker (SYK) and Wright...

Stephen Simpson, CFA on Seeking Alpha | October 1, 2020

Smith & Nephew revenue slide to slow in third quarter

Medical prosthetics maker Smith & Nephew Plc expects its decline in underlying revenue to be just 4% in the third quarter of this year, down from almost 30% in the previous three months when it was suffering heavily from the impact of coronavirus lockdowns and a halt…

Reuters | October 1, 2020

Integra LifeSciences: A Small Deal, Reveals Appeal?

Integra LifeSciences (IART) announced a small divestment. This transaction and the fact that this stock is undercovered on this platform are enough of a reason to create an investment thesis on the stock. This reveals quite modest valuations given the activities of the underlying business, organic growth and valuation multiples....

The Value Investor on Seeking Alpha | September 30, 2020

Arthroscopic Devices Market Size and Prediction by Leading Manufacturers According to Its Application and Types Till 2027 | Smith & Nephew, DePuy Synthes, Stryker, Arthrex, etc

According to the current analysis of Reports and Data, the global Arthroscopic Devices market was valued at USD 4.32 billion in 2018 and is expected to reach USD 7.05 billion by the year 2026, at a CAGR of 6.2 %.

OpenPR | September 30, 2020

Surgical Robots Market 2020 Segments Analysis: Intuitive Surgical, Accuray Incorporated, Stryker, MEDTRONIC, Smith & Nephew

"Surgical Robots Market" By Product Type (Instruments, Robotic Systems, Accessories and Services), Brands (DA Vinci Surgical System, CyberKnife, Renaissance, Artas, ROSA, Others), Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy, Others), Geography (Europe, North America,

OpenPR | September 29, 2020

Read More 'SNN' Stories Here

SNN Price Returns

1-mo 11.15%
3-mo -3.42%
6-mo -6.53%
1-year -11.14%
3-year 15.10%
5-year 25.28%
YTD -17.22%
2019 30.78%
2018 8.84%
2017 18.54%
2016 -13.98%
2015 -1.43%

SNN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SNN Dividend History

Continue Researching SNN

Here are a few links from around the web to help you further your research on Smith & Nephew Plc's stock as an investment opportunity:

Smith & Nephew Plc (SNN) Stock Price | Nasdaq
Smith & Nephew Plc (SNN) Stock Quote, History and News - Yahoo Finance
Smith & Nephew Plc (SNN) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8554 seconds.